⌘K

Login Start Free

Home/Filings/4/0001348362-25-000014

4//SEC Filing

DOCHERTY JOHN MARTIN 4

Accession 0001348362-25-000014

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 11:34 AM ET

Size

13.8 KB

Accession

0001348362-25-000014

Insider Transaction Report

Form 4

Period: 2025-07-29

Lexaria Bioscience Corp.LEXX

DOCHERTY JOHN MARTIN

DirectorPresident

Transactions

Purchase
common shares
2025-07-29$0.93/sh+5,376$4,989→ 5,376 total

Holdings

Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (18,334 underlying)
36,334
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (15,000 underlying)
51,334
Stock Options
Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (30,000 underlying)
111,334
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (49,500 underlying)
160,834
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (18,000 underlying)
18,000
common shares
(indirect: Private Holding Company)
54,075
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (30,000 underlying)
81,334
Stock Options
Exercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (150,000 underlying)
310,834

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001638727

Filing Metadata

Form type: 4
Filed: Jul 29, 8:00 PM ET
Accepted: Jul 30, 11:34 AM ET
Size: 13.8 KB

View on SEC.gov